Health
Erythropoietin treatment may increase the risk of hip fractures in individuals with kidney failure – News-Medical.Net
Erythropoietin (EPO) is a medication used to stimulate the production of new red blood cells, which is impaired in individuals with kidney failure. Unfortunately,…
Erythropoietin (EPO) is a medication used to stimulate the production of new red blood cells, which is impaired in individuals with kidney failure. Unfortunately, however, the treatment may increase the risk of hip fractures.
In an analysis published in the Journal of Bone and Mineral Research that examined 1997-2013 records from two large U.S. databases, investigators found that EPO doses administered to patients with kidney failure on hemodialysis fluctuated widely over time, and hip fracture…
-
Noosa News21 hours agoEnsure voices are heard – Proctor
-
Business19 hours agoUp 34% this year, can Challenger shares keep rising according to Macquarie?
-
Noosa News23 hours agoCity of Moreton Bay claims homeless people consented to having camps thrown away
-
General22 hours agoReserve Bank board still looking for yesterday’s news